These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35973850)

  • 1. Use of pharmacological treatment for posttraumatic stress disorder: Analysis of a psychiatric population in Switzerland and comparison with international guidelines.
    Montavon F; Vandenberghe F; Eap CB
    Encephale; 2023 Oct; 49(5):446-452. PubMed ID: 35973850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003-2010.
    Hawkins EJ; Malte CA; Imel ZE; Saxon AJ; Kivlahan DR
    Drug Alcohol Depend; 2012 Jul; 124(1-2):154-61. PubMed ID: 22305658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of 1,044 inpatients with posttraumatic stress disorder: current status and trends in German-speaking countries.
    Reinhard MA; Seifert J; Greiner T; Toto S; Bleich S; Grohmann R
    Eur Arch Psychiatry Clin Neurosci; 2021 Sep; 271(6):1065-1076. PubMed ID: 33369692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing trends in veterans with posttraumatic stress disorder.
    Bernardy NC; Lund BC; Alexander B; Friedman MJ
    J Clin Psychiatry; 2012 Mar; 73(3):297-303. PubMed ID: 22490256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance between psychotropic prescribing for veterans with PTSD and clinical practice guidelines.
    Jain S; Greenbaum MA; Rosen C
    Psychiatr Serv; 2012 Feb; 63(2):154-60. PubMed ID: 22302333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in medication prescribing patterns for veterans with posttraumatic stress disorder: A 10-year follow-up study.
    Hadlandsmyth K; Bernardy NC; Lund BC
    J Trauma Stress; 2022 Dec; 35(6):1586-1597. PubMed ID: 35797242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for posttraumatic stress disorder: review with clinical applications.
    Jeffreys M; Capehart B; Friedman MJ
    J Rehabil Res Dev; 2012; 49(5):703-15. PubMed ID: 23015581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for posttraumatic stress disorder at a Veterans Affairs facility.
    Kobayashi TM; Patel M; Lotito M
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S11-5. PubMed ID: 25991587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
    Agius M; Gardner J; Liu K; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):346-9. PubMed ID: 20562779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM; Kohn SR; Henderson M; Brown NL
    Drugs; 2004; 64(4):383-404. PubMed ID: 14969574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
    Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
    J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicidality in patients with post-traumatic stress disorder and its association with receipt of specific secondary mental healthcare treatments.
    Opie E; Werbeloff N; Hayes J; Osborn D; Pitman A
    Int J Psychiatry Clin Pract; 2023 Jun; 27(2):151-160. PubMed ID: 36369845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.
    Abrams TE; Lund BC; Bernardy NC; Friedman MJ
    Psychiatr Serv; 2013 Feb; 64(2):142-8. PubMed ID: 23474508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cultivating change door to door: Educational outreach to improve prescribing practices in rural veterans with posttraumatic stress disorder.
    Montaño M; Bernardy NC; Sherrieb K
    Subst Abus; 2017; 38(2):129-134. PubMed ID: 28277828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of alternative antidepressant agent initiation among U. S. veterans diagnosed with depression.
    Kim HM; Zivin K; Ganoczy D; Pfeiffer P; Hoggatt K; McCarthy JF; Downing K; Valenstein M
    Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1049-56. PubMed ID: 20629192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators.
    Forns J; Pottegård A; Reinders T; Poblador-Plou B; Morros R; Brandt L; Cainzos-Achirica M; Hellfritzsch M; Schink T; Prados-Torres A; Giner-Soriano M; Hägg D; Hallas J; Cortés J; Jacquot E; Deltour N; Perez-Gutthann S; Pladevall M; Reutfors J
    J Affect Disord; 2019 Apr; 249():242-252. PubMed ID: 30780117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing Medications for DSM-5 PTSD in Routine VA Practice.
    Shiner B; Leonard CE; Gui J; Cornelius SL; Schnurr PP; Hoyt JE; Young-Xu Y; Watts BV
    J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33049805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy.
    Di Nicola M; Dell'Osso B; Peduto I; Cipelli R; Pugliese AC; Signorelli MS; Ventriglio A; Martinotti G
    Curr Neuropharmacol; 2023; 21(3):727-739. PubMed ID: 35410606
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.